Integra LifeSciences IART Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Integra LifeSciences’s reported figures.
Based on trailing twelve months.
The official record: Integra LifeSciences’s 10-Q, filed July 31, 2025, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's free cash flow margin?
- Integra LifeSciences (IART) reported free cash flow margin of 3.8% in Q2 2024.
- How has Integra LifeSciences's free cash flow margin changed year-over-year?
- Integra LifeSciences's free cash flow margin decreased by 62.6% year-over-year, from 10% to 3.8%.
- What is the long-term trend for Integra LifeSciences's free cash flow margin?
- Over 3 years (2020 to 2023), Integra LifeSciences's free cash flow margin has grown at a -26.7% compound annual growth rate (CAGR), from 12% to 4.7%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.